Subgroup registry analysis evaluates mid-term outcomes of drug-coated balloons in dyslipidemia, indicating treatment utility for infrainguinal disease.
The aim of this study was to assess the mid-term outcomes of the use of drug-coated balloons (DCBs) to treat infrainguinal peripheral arterial disease (PAD) in patients with dyslipidemia.
No takes yet. Share an insight, caveat, or question.
Dodd et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: